ArticleTherapeutic advances in gastroenterology2026
An inverse probability of treatment weighted comparison between vedolizumab, ustekinumab, and tofacitinib in anti-TNF-experienced ulcerative colitis patients.
Antonio Tursi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.